A Prevention Trial in Subjects at High Risk for Breast Cancer

NCT01500577 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: nimesulide
DRUG: Simvastatin
OTHER: Placebo

Sponsor

European Institute of Oncology